# Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women

> **NCT05854992** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 68419 (actual)

## Conditions studied

- Migraine
- Cardiovascular Diseases
- Pregnancy

## Interventions

- **DRUG:** Acute migraine treatment with any prescribed triptans
- **DRUG:** Standard of care management of acute migraine without triptans

## Key facts

- **NCT ID:** NCT05854992
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-05
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 68419 (ACTUAL)
- **Last updated:** 2024-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05854992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05854992, "Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05854992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*